Bionime Corp
TWSE:4737
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bionime Corp
Deferred Income Tax
Bionime Corp
Deferred Income Tax Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bionime Corp
TWSE:4737
|
Deferred Income Tax
NT$1.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
53%
|
CAGR 10-Years
-5%
|
|
|
M
|
Medimaging Integrated Solution Inc
TWSE:6796
|
Deferred Income Tax
NT$2.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Apex Biotechnology Corp
TWSE:1733
|
Deferred Income Tax
NT$10.8m
|
CAGR 3-Years
52%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Wellell Inc
TWSE:4106
|
Deferred Income Tax
NT$4.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
|
Applied BioCode Corp
TWSE:6598
|
Deferred Income Tax
NT$3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Bionime Corp
Glance View
Bionime Corp. engages in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company is headquartered in Taichung, Taichung. The company went IPO on 2009-08-26. The firm's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The firm distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
See Also
What is Bionime Corp's Deferred Income Tax?
Deferred Income Tax
1.8m
TWD
Based on the financial report for Sep 30, 2025, Bionime Corp's Deferred Income Tax amounts to 1.8m TWD.
What is Bionime Corp's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-5%
Over the last year, the Deferred Income Tax growth was 279%. The average annual Deferred Income Tax growth rates for Bionime Corp have been 31% over the past three years , 53% over the past five years , and -5% over the past ten years .
